Control Bionics (ASX:CBL) EBITDA Margin % : -97.59% (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Control Bionics EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Control Bionics's EBITDA for the six months ended in Dec. 2024 was A$-2.71 Mil. Control Bionics's Revenue for the six months ended in Dec. 2024 was A$2.78 Mil. Therefore, Control Bionics's EBITDA margin for the quarter that ended in Dec. 2024 was -97.59%.

Control Bionics EBITDA Margin % Historical Data

The historical data trend for Control Bionics's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Control Bionics EBITDA Margin % Chart

Control Bionics Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

EBITDA Margin %

-84.50

-127.49

-94.54

-97.80

Control Bionics Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBITDA Margin %	Get a 7-Day Free Trial				-99.53	-89.41	-67.53	-135.46	-97.59

Competitive Comparison of Control Bionics's EBITDA Margin %

For the Medical Devices subindustry, Control Bionics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Control Bionics's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Control Bionics's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Control Bionics's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Control Bionics EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Control Bionics's EBITDA Margin % for the fiscal year that ended in Jun. 2024 is calculated as

EBITDA Margin %	=	EBITDA (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	-5.014	/	5.127
	=	-97.80 %

Control Bionics's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-2.711	/	2.778
	=	-97.59 %

Control Bionics (ASX:CBL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Control Bionics EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Control Bionics's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Control Bionics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121

Website

https://www.controlbionics.com

Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.